Dr. Reddy's Laboratories Limited
RDY
$13.47
$0.060.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 164.61M | 165.68M | 184.13M | 167.32M | 149.86M |
| Total Depreciation and Amortization | 57.86M | 55.68M | 52.61M | 55.87M | 47.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.81M | 45.31M | 10.63M | -30.59M | 6.83M |
| Change in Net Operating Assets | -29.28M | -95.72M | 6.75M | -114.22M | -92.93M |
| Cash from Operations | 178.38M | 170.95M | 254.12M | 78.37M | 111.22M |
| Capital Expenditure | -59.83M | -80.17M | -88.52M | -85.19M | -89.97M |
| Sale of Property, Plant, and Equipment | 1.26M | 373.90K | -115.50K | 1.31M | 2.52M |
| Cash Acquisitions | -- | -- | -19.12M | 0.00 | -614.12M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.74M | -144.47M | -45.90M | 19.26M | 473.89M |
| Cash from Investing | -109.31M | -224.27M | -153.66M | -64.62M | -227.68M |
| Total Debt Issued | 2.61B | 70.00M | -4.89B | 1.83B | 16.99B |
| Total Debt Repaid | -239.00M | -326.00M | -253.00M | -306.00M | -435.00M |
| Issuance of Common Stock | 92.00M | 196.00M | 11.00M | 25.00M | 138.00M |
| Repurchase of Common Stock | -- | -- | -1.39B | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -76.27M | -- | 0.00 | 0.00 | -79.53M |
| Other Financing Activities | -1.12B | -1.14B | -846.00M | -956.00M | 6.12B |
| Cash from Financing | -60.97M | -14.06M | -85.15M | 6.98M | 192.81M |
| Foreign Exchange rate Adjustments | 2.23M | 2.07M | 2.72M | -59.20K | -274.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.33M | -65.31M | 18.03M | 20.68M | 76.07M |